Yahoo Finance Surgical Innovations Group Reports Full Year 2023 Earnings
Surgical Innovations Group (LON:SUN) Full Year 2023 Results
Key Financial Results
Revenue: UK£12.0m (up 5.9% from FY 2022).
Net loss: UK£509.0k (down by 293% from UK£264.0k profit in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Surgical Innovations Group shares are up 11% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 2 warning signs for Surgical Innovations Group (1 is significant!) that you need to be mindful of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
